Understanding risk for psychopathology through imaging gene-environment interactions

Trends in Cognitive Sciences

Volumn 15, Issue 9, 2011, Pages 417-427

  Hyde, Luke W ^a   Bogdan, Ryan ^b   Hariri, Ahmad R ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MECHANISMS; E-MODEL; EPIGENETICS; GENE-ENVIRONMENT INTERACTION;

GENES;

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; SEROTONIN TRANSPORTER;

5 HTT GENE; AMYGDALOID NUCLEUS; BEHAVIOR; BIOLOGICAL MODEL; CONCEPTUAL FRAMEWORK; DEPRESSION; DNA POLYMORPHISM; EPIGENETICS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIFE STRESS; NONHUMAN; PERSONAL EXPERIENCE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PROMOTER REGION; REVIEW; STATISTICAL MODEL;

BRAIN; EPIGENOMICS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, BIOLOGICAL; NEUROIMAGING; PSYCHOPATHOLOGY;

EID: 80051952765     PISSN: 13646613     EISSN: 1879307X     Source Type: Journal    
DOI: 10.1016/j.tics.2011.07.001     Document Type: Review

References (94)

1. Hariri A.R. The neurobiology of individual differences in complex behavioral traits. Annu. Rev. Neurosci. 2009, 32:225-247.
2. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 2006, 7:583-590.
3. Caspi A., et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 2010, 167:509-527.
4. Meaney M.J. Epigenetics and the biological definition of gene×environment interactions. Child Dev. 2010, 81:41-79.
5. Moffitt T.E., et al. Strategy for investigating interactions between measured genes and measured environments. Arch. Gen. Psychiatry 2005, 62:473-481.
6. Hariri A.R., et al. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol. Psychiatry 2006, 59:888-897.
7. Caspi A., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
8. Karg K., et al. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 2011, 68:444-454.
9. Caspi A., et al. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
10. Caspi A., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57:1117-1127.
11. Maher B. Personal genomes: the case of the missing heritability. Nature 2008, 456:18-21.
12. Plomin R. Finding genes in child psychology and psychiatry: when are we going to be there?. J. Child Psychol. Psychiatry 2005, 46:1030-1038.
13. Heiming R.S., Sachser N. Consequences of serotonin transporter genotype and early adversity on behavioral profile - pathology or adaptation?. Front. Neurosci. 2010, 4:187.
14. Belsky J., Pluess M. Beyond diathesis stress: differential susceptibility to environmental influences. Psychol. Bull. 2009, 135:885-908.
15. Ellis B.J., Boyce W.T. Differential susceptibility to the environment: toward an understanding of sensitivity to developmental experiences and context. Dev. Psychopathol. 2011, 23:1-5.
16. Manuck S.B. The reaction norm in gene×environment interaction. Mol. Psychiatry 2009, 15:881-882.
17. Manuck S.B., McCaffery J.M. Genetics of stress: gene-stress correlation and interaction. Handbook of Behavioral Medicine: Methods and Applications 2010, 454-478. Springer. A. Steptoe (Ed.).
18. Franklin T.B., Mansuy I.M. Epigenetic inheritance in mammals: evidence for the impact of adverse environmental effects. Neurobiol. Dis. 2010, 39:61-65.
19. Jaffee S.R. Genotype-environment correlations: definitions, methods of measurement and implications for research on adolescent pscyhopathology. The Dynamic Genome and Mental Health 2011, 79-102. Oxford. K.S. Kendler (Ed.).
20. Reiss D., Leve L.D. Genetic expression outside the skin: clues to mechanisms of Genotype×Environment interaction. Dev. Psychopathol. 2007, 19:1005-1027.
21. Leve L.D., et al. Infant pathways to externalizing behavior: evidence of Genotype×Environment interaction. Child Dev. 2010, 81:340-356.
22. Jaffee S.R., et al. Nature×nurture: genetic vulnerabilities interact with physical maltreatment to promote conduct problems. Dev. Psychopathol. 2005, 17:67-84.
23. Kilpatrick D.G., et al. The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am. J. Psychiatry 2007, 164:1693-1699.
24. Costello E.J., et al. Relationships between poverty and psychopathology. JAMA 2003, 290:2023-2029.
25. King A.P., Liberzon I. Assessing the neuroendocrine stress response in the functional neuroimaging context. Neuroimage 2009, 47:1116-1124.
26. Bennett A., et al. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol. Psychiatry 2002, 7:118-122.
27. Brody G.H., et al. Prevention effects moderate the association of 5 HTTLPR and youth risk behavior initiation: gene×environment hypotheses tested via a randomized prevention design. Child Dev. 2009, 80:645-661.
28. Kaufman J., et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17316-17321.
29. Rutter M., Dodge K.A. Gene-environment interactions: the state of science. Gene-Environment Interaction in Developmental Psychopathology 2011, 87-101. Guilford. K.A. Dodge, M. Rutter (Eds.).
30. Wenten M., et al. Functional variants in the catalase and myeloperoxidase genes, ambient air pollution, and respiratory-related school absences: an example of epistasis in gene-environment interactions. Am. J. Epidemiol. 2009, 170:1494-1501.
31. McClelland G.H., Judd C.M. Statistical difficulties of detecting interactions and moderator effects. Psychol. Bull. 1993, 114:376-390.
32. Weder N., et al. MAOA genotype, maltreatment, and aggressive behavior: the changing impact of genotype at varying levels of trauma. Biol. Psychiatry 2009, 65:417-424.
33. Uher R. Gene-environment interactions. The Dynamic Genome and Mental Health 2011, 29-58. Oxford. K.S. Kendler (Ed.).
34. Eaves L., et al. Resolving multiple epigenetic pathways to adolescent depression. J. Child Psychol. Psychiatry 2003, 44:1006-1014.
35. Eaves L. Genotype×environment interaction in psychopathology: factor or artifact?. Twin Res. Hum. Genet. 2006, 36:74-87.
36. Kendler K.S. A conceptual overview of gene-environment interaction and correlation in a developmental context. The Dynamic Genome and Mental Health 2011, Oxford, pp. 5-28. K.S. Kendler (Ed.).
37. Risch N., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression. J. Am. Med. Assoc. 2009, 301:2462-2471.
38. Uher R., McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol. Psychiatry 2010, 15:18-22.
39. Lenroot R.K., Giedd J.N. Annual Research Review: developmental considerations of gene by environment interactions. J. Child Psychol. Psychiatry 2011, 52:429-441.
40. Sjöberg R.L., et al. Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors. Am. J. Med. Genet. B 2006, 144:159-164.
41. Serretti A., et al. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol. Psychiatry 2006, 12:247-257.
42. Munafò M.R., et al. 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am. J. Med. Genet. B 2009, 150:271-281.
43. Widom C.S., Brzustowicz L.M. MAOA and the " cycle of violence:" childhood abuse and neglect, MAOA genotype, and risk for violent and antisocial behavior. Biol. Psychiatry 2006, 60:684-689.
44. Cardon L.R., Palmer L.J. Population stratification and spurious allelic association. Lancet 2003, 361:598-604.
45. Blakely R., Veenstra-Vanderweele J. Genetic indeterminism, the 5-HTTLPR, and the paths forward in neuropsychiatric genetics. Arch. Gen. Psychiatry 2011, 68:457-458.
46. Meyer-Lindenberg A. Neurogenetic mechanisms of gene-environment interactions. Gene-Environment Interactions in Developmental Psychopathology 2011, 71-87. Guilford. K.A. Dodge, M. Rutter (Eds.).
47. Hariri A.R., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
48. Pezawas L., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
49. Fakra E., et al. Effects of HTR1A C (-1019) G on amygdala reactivity and trait anxiety. Arch. Gen. Psychiatry 2009, 66:33-40.
50. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35:192-216.
51. Lesch K.P., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
52. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci. Biobehav. Rev. 2008, 32:1293-1314.
53. Fisher P.M., et al. Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat. Neurosci. 2006, 9:1362-1363.
54. Bigos K.L., et al. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33:3221-3225.
55. Andreasen N.C. Schizophrenia: the fundamental questions. Brain Res. Rev. 2000, 31:106-112.
56. Hasler G., Northoff G. Discovering imaging endophenotypes for major depression. Mol. Psychiatry 2011, 1:1-16.
57. Furmark T., et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J. Neurosci. 2008, 28:13066-13074.
58. Preacher K.J., et al. Addressing moderated mediation hypotheses: theory, methods, and prescriptions. Multivariate Behav. Res. 2007, 42:185-227.
59. Talkowski M.E., et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 2008, 17:747-758.
60. Buckholtz J., et al. fMRI evidence for functional epistasis between COMT and RGS4. Mol. Psychiatry 2007, 12:893-895.
61. Nikolova Y.S., et al. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology. 2011, 36:1940-1947.
62. Liu X., et al. A genome-wide association study of amygdala activation in youths with and without bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 2010, 49:33-41.
63. Ege M.J., et al. Gene-environment interaction for childhood asthma and exposure to farming in Central Europe. J. Allergy Clin. Immunol. 2011, 127:138-144.
64. Gruenewald T.L., et al. Combinations of biomarkers predictive of later life mortality. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:14158-14163.
65. Hizer S.E., et al. Genetic markers applied in regression tree prediction models. Anim. Genet. 2004, 35:50-52.
66. Pereira F., et al. Machine learning classifiers and fMRI: a tutorial overview. Neuroimage 2009, 45:S199-S209.
67. Astolfi L., et al. Imaging functional brain connectivity patterns from high resolution EEG and fMRI via graph theory. Psychophysiology 2007, 44:880-893.
68. Ressler K.J., et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011, 470:492-497.
69. Casey B.J., et al. Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience 2009, 164:108-120.
70. Kohli M.A., et al. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 2011, 70:252-265.
71. Gerritsen L., et al. BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects. Mol. Psychiatry 2011, 10.1038/mp.2011.51.
72. Tottenham N., et al. Elevated amygdala response to faces following early deprivation. Dev Sci. 2011, 14:190-204.
73. Butterworth P., et al. The association between financial hardship and amygdala and hippocampal volumes: results from the PATH through life project. Soc. Cogn. Affect Neurosci. 2011, 10.1093/scan/nsr027.
74. Schumann G., et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol. Psychiatry 2010, 15:1128-1139.
75. Fowler J.S., et al. Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol. Psychiatry 2007, 62:355-358.
76. Sibille E., Lewis D.A. SERT-ainly involved in depression, but when?. Am. J. Psychiatry 2006, 163:8-11.
77. Jedema H.P., et al. Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission. Mol. Psychiatry 2009, 15:512-522.
78. Sroufe L.A., Rutter M. The domain of developmental psychopathology. Child Dev. 1984, 55:17-29.
79. Kendler K.S., Myers J. A developmental twin study of church attendance and alcohol and nicotine consumption: a model for analyzing the changing impact of genes and environment. Am. J. Psychiatry 2009, 166:1150-1155.
80. Tada T., Sheng M. Molecular mechanisms of dendritic spine morphogenesis. Curr. Opin. Neurobiol. 2006, 16:95-101.
81. Kandel E.R. Cellular mechanisms of learning and the biological basis of individuality. Principles of Neural Science 4th edn 1991, 1247-1279. McGraw-Hill. E.R. Kandel (Ed.).
82. Zhang T.Y., Meaney M.J. Epigenetics and the environmental regulation of the genome and its function. Annu. Rev. Psychol. 2010, 61:439-466.
83. Mill J. Epigenetic effectson gene function and their role in mediating gene-environment interactions. The Dynamic Genome and Mental Health 2011, 145-171. Oxford. K.S. Kendler (Ed.).
84. Roth T.L., Sweatt J.D. Annual Research Review: epigenetic mechanisms and environmental shaping of the brain during sensitive periods of development. J. Child Psychol. Psychiatry 2011, 52:398-408.
85. Weaver I.C.G., et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
86. McGowan P.O., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
87. Tsankova N., et al. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 2007, 8:355-367.
88. Masten A.S. Ordinary magic. Resilience processes in development. Am. Psychol. 2001, 56:227-238.
89. Fraga M.F., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10604-10609.
90. Ursini G., et al. Stress-related methylation of the catechol-O-methyltransferase Val158 allele predicts human prefrontal cognition and activity. J. Neurosci. 2011, 31:6692-6698.
91. Willard H.F., Ginsburg G.S. Essentials of Genomic and Personalized Medicine 2009, Academic Press.
92. Mehta D., et al. Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry 2011, 10.1001/archgenpsychiatry.2011.50.
93. Hariri A.R., et al. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol. Psychiatry 2009, 66:9-16.
94. Hyde L.W., et al. Social support moderates the link between amygdala reactivity and trait anxiety. Neuropsychologia 2011, 49:651-656.